IMVT Competitors & Alternatives
Compare Immunovant Inc with similar stocks in the same industry
Biotechnology
IMVT
Main Stock$37.61
Tradestie Score
63
Market Cap
$2.85B
Analyst Upside
+21.7%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$168.12
|
$8.57B | - | 58 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$17.77
|
$8.53B | - | 60 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$227.57
|
$8.30B | 2042.4 | 61 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$79.16
|
$6.68B | - | 61 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$105.42
|
$6.64B | - | 65 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$98.01
|
$6.38B | - | 50 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.57
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$54.27
|
$6.02B | - | 58 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.43
|
$5.95B | - | 61 | Compare |
More IMVT Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry